๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Gastroesophageal Junction Cancer

A Multicenter Cancer Biospecimen Collection Study NCT04510129n/a1 site๐Ÿ“ San Francisco Cofactor Genomics, Inc. ยท Tests: OncoPrismโ„ข assay Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ Adenocarcinoma NCT04997837Phase 31 site๐Ÿ“ Shanghai Fudan University ยท Tests: PD-1 inhibitor, Oxaliplatin, Capecitabine, Tegafur-gimeracil-oteracil potassium, 5-FU Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction Adenocarcinoma NCT06461910Phase 21 site๐Ÿ“ Nanjing Zekuan Xu ยท Tests: Serplulimab, thymalfasin, Oxaliplatin, Tegafur AK104 in Combination With AK112 Plus Chemotherapy(SOX/XELOX) as First-line Treatment for Advanced G/GEJ Cancer NCT06196697Phase 21 site๐Ÿ“ Harbin Harbin Medical University ยท Tests: Cadonilimab, Ivonescimab, XELOX, SOX Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors NCT07660055Phase 15 sites๐Ÿ“ Omaha๐Ÿ“ Darlinghurst๐Ÿ“ Montreal Novartis Pharmaceuticals ยท Tests: [68Ga]Ga-DWJ155, [177Lu]Lu-DWJ155 A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma NCT07069712Phase 270 sites๐Ÿ“ Newark๐Ÿ“ Washington D.C.๐Ÿ“ Fairway AstraZeneca ยท Tests: Sonesitatug Vedotin, Rilvegostomig, Trastuzumab Deruxtecan (T-DXd), Capecitabine, 5-Fluorouracil (5-FU) Comparing Modified XELOX Plus Sintilimab With Standard XELOX Plus Sintilimab in First-line Treatment for HER2-negative Gastric/Gastroesophageal Junction Adenocarcinoma NCT05918094Phase 310 sites๐Ÿ“ Guangzhou๐Ÿ“ Guiyang๐Ÿ“ Harbin Sun Yat-sen University ยท Tests: Experimental dose: modified XELOX + sintilimab, Standard dose: standard XELOX + sintilimab Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection NCT05334069n/a747 sites๐Ÿ“ Anchorage๐Ÿ“ Anchorage๐Ÿ“ Anchorage Alliance for Clinical Trials in Oncology ยท Tests: Questionnaire Administration, Biospecimen Collection Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemotherapy for the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma. NCT07385703Phase 3106 sites๐Ÿ“ Hefei๐Ÿ“ Hefei๐Ÿ“ Hefei Shanghai Chia Tai Tianqing Pharmaceutical Technology Develoโ€ฆ ยท Tests: LM-302 Injection, Tislelizumab, Oxaliplatin Injection, Capecitabine Tablets Perioperative FLOT vs Adjuvant XELOX for CA Stomach NCT05264896Phase 31 site๐Ÿ“ Hong Kong Chinese University of Hong Kong ยท Tests: 5-FU, Leucovorin, Oxaliplatin, Docetaxel, XELOX XELOX Combined With Sintilimab and HBO for Advanced or Metastatic GC/GEJC NCT06742411Phase 1, Phase 22 sites๐Ÿ“ Chengdu๐Ÿ“ Chengdu West China Hospital ยท Tests: XELOX+Sintilimab+HBOT A Study of Sigvotatug Vedotin in Advanced Solid Tumors NCT04389632Phase 1158 sites๐Ÿ“ Anchorage๐Ÿ“ Fayetteville๐Ÿ“ Rogers Seagen, a wholly owned subsidiary of Pfizer ยท Tests: sigvotatug vedotin, pembrolizumab, cisplatin, carboplatin A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors NCT07287995Phase 1, Phase 29 sites๐Ÿ“ Celebration๐Ÿ“ Hackensack๐Ÿ“ New Hyde Park Astellas Pharma Global Development, Inc. ยท Tests: ASP2998, Pembrolizumab, Enfortumab Vedotin, Carboplatin Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric Cancer NCT07334431Phase 1, Phase 21 site๐Ÿ“ Zhengzhou Henan Cancer Hospital ยท Tests: fruquintinib๏ผ‹trastuzumab + XELOX Timing of Comprehensive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma NCT07000253Phase 25 sites๐Ÿ“ Amsterdam๐Ÿ“ Utrecht๐Ÿ“ Oslo Academisch Medisch Centrum - Universiteit van Amsterdam (AMโ€ฆ ยท Tests: Chemotherapy, Targeted Systemic Therapy, Immunotherapy, Surgery, Radiotherapy A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors NCT06131840Phase 148 sites๐Ÿ“ Phoenix๐Ÿ“ Scottsdale๐Ÿ“ Duarte Seagen, a wholly owned subsidiary of Pfizer ยท Tests: PF-08046050, bevacizumab, 5-Fluorouracil (5-FU), Oxaliplatin, Leucovorin (LV) A Study in Greece Observing How Patients With Stomach and Esophageal Cancer Are Diagnosed and Treated in Everyday Medical Practice NCT07800754n/a8 sites๐Ÿ“ Alexandroupoli๐Ÿ“ Athens๐Ÿ“ Athens AstraZeneca A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204) NCT07221149Phase 2, Phase 3161 sites๐Ÿ“ Phoenix๐Ÿ“ Los Angeles๐Ÿ“ Orange Bristol-Myers Squibb ยท Tests: Pumitamig, Folfox, Capox, Nivolumab Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity NCT07001748Phase 2, Phase 378 sites๐Ÿ“ Irvine๐Ÿ“ Los Angeles๐Ÿ“ Orange ECOG-ACRIN Cancer Research Group ยท Tests: Standard of Care Chemotherapy, Biospecimen Collection, Computed Tomography, Diagnostic Laparoscopy, Intraperitoneal Porโ€ฆ M108 Plus CAPOX Versus Placebo Plus CAPOX as First-line Treatment for Claudin (CLDN) 18.2-Positive, HER2-Negative, PD-L1 CPS<5, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma. NCT06177041Phase 31 site๐Ÿ“ Beijing FutureGen Biopharmaceutical (Beijing) Co., Ltd ยท Tests: M108 monoclonal antibody, Placebo, Oxaliplatin, Capecitabine Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors NCT06293898Phase 126 sites๐Ÿ“ Birmingham๐Ÿ“ Duarte๐Ÿ“ Los Angeles SystImmune Inc. ยท Tests: BL-M07D1 Low-dose Radiotherapy Combined With Chemotherapy and AK112 as Second-line Treatment in Patients With Advanced G/GEJ Cancer NCT06791148Phase 21 site๐Ÿ“ Nanjing The Affiliated Nanjing Drum Tower Hospital of Nanjing Univeโ€ฆ ยท Tests: Low-dose radiotherapy, albumin-bound paclitaxel, AK112 Semmelweis Esophageal Cancer Study: Noninvasive Prognostic Parameters in Patients With Oesophageal and Esophagogastric Junction Cancer NCT06713993n/a1 site๐Ÿ“ Budapest Semmelweis University Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers NCT04221893NA2 sites๐Ÿ“ San Francisco๐Ÿ“ Walnut Creek University of California, San Francisco ยท Tests: Radiation Therapy (RT) A Phase 2 Clinical Study of ABSK061 and ABSK043 NCT06632262Phase 221 sites๐Ÿ“ Guiyang๐Ÿ“ Guiyang๐Ÿ“ Shijiazhuang Abbisko Therapeutics Co, Ltd ยท Tests: ABSK061 + ABSK043, ABSK061+ABSK043 in combination with CAPOX Silent Evaluation of DeepTRG for Assessing Tumor Response After Preoperative Treatment in Stomach and Gastroesophageal Junction Cancer NCT07849608n/a1 site๐Ÿ“ Shijiazhuang Qun Zhao ยท Tests: AI-Based Digital Pathology Assessment of Treatment Response (DeepTRG) A Phase Ib/II Study of Adebrelimab in Combination with Capecitabine and Oxaliplatin in Cancer NCT06776770Phase 1, Phase 21 site๐Ÿ“ Shenzhen Cancer Hospital Chinese Academy of Medical Science, Shenzheโ€ฆ ยท Tests: Adebrelimab A Prospective Study on Esophagogastrostomy by an Innovative Surgical Technique NCT06300879NA1 site๐Ÿ“ Shanghai Huashan Hospital ยท Tests: Performing totally laparoscopic proximal gastrectomy with esophagogastrostomy by fissure technique CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors NCT05733000Phase 21 site๐Ÿ“ Chicago Northwestern University ยท Tests: Biospecimen Collection, Computed Tomography, Devimistat, Fluorouracil, Gemcitabine Hydrochloride Disitamab Vedotin Plus Trastuzumab in Patients With HER2 Positive GC/GEJ Patiens NCT06572319Phase 1, Phase 21 site๐Ÿ“ Hangzhou Zhejiang Cancer Hospital ยท Tests: Disitamab Vedotin(RC48) Plus Tratuzumab
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy